Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Aptamers May Form New, Safer Chemotherapy Delivery Systems

Using chemotherapy along with aptamers—lab-made molecules that function like antibodies—Duke Health researchers showed that they can zero in on and kill prostate cancer tumors in mice while leaving healthy tissue unscathed. The finding suggests that aptamers could form the basis of new cancer...

Duke Nurse Turned Cancer Survivor

Bethany Clements, 54, has been an oncology nurse at Duke Cancer Institute for the past 25 years. Clements dedicated her career to helping others battling cancer, but in May 2011 she found herself facing her own personal battle with the disease. During one evening work shift, Clements, in an ironic...

New Antibody May Re-Activate Immune System in Cancer Therapy

Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept study by Duke Cancer Institute researchers. The study, published June 28 in...

How Common Chemotherapy Drugs Work

A study by scientists at Duke Health is providing insight into how certain commonly-used chemotherapy drugs work, potentially opening new ways to enhance the benefits of treatment for cancer patients. The scientists focused on antimetabolites, chemotherapy drugs that target metabolism in cancer...

Shared Resource: Investigational Chemotherapy Service Lab

The Investigational Chemotherapy Service is one of two labs making up the Pharmaceutical Shared Resource. Putting a new cancer medication through the early stages of clinical trials is an intimidatingly complex process. A proper dosage regimen must be tailored for every patient. Medications may...